Particle Therapy 2017

1368-1369 / 2605

Phases of clinical research (2)
• Phase I
– Safety
– Often dose escalation (MTD)
– 10-50 patients
• Phase II
– Efficacy (primary endpoint)
– Safety (secondary endpoint)
– In radiotherapy often including optimization
– Trend towards randomized phase II
– 50-300 patients